{"status": "OK", "response": {"docs": [{"type_of_material": "Obituary; Biography", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "Daniel Patrick Moynihan, the Harvard professor and four-term United States senator from New York who brought a scholar's eye for data to politics and a politician's sense of the real world to academia, died yesterday at Washington Hospital Center in Washington, D.C. He was 76. The cause, a spokesman for the family said, was complications of a ruptured appendix, which was removed on March 11 at the hospital, where he remained.", "headline": {"main": "Daniel Patrick Moynihan Is Dead; Senator From Academia Was 76"}, "abstract": "Daniel Patrick Moynihan, Harvard professor and four-term United States senator from New York, dies at age of 76; brought scholar's eye for data to politics and politician's sense of real world to academia; was always more a man of ideas than of legislation or partisan combat; was enough of politician to win re-election easily, and enough of maverick with close Republican friends to be occasional irritant to his Democratic party leaders; served in Senate from 1977 to 2001; before that he served two Democratic presidents and two Republicans; for more than 40 years, in and out of government, he was known for being among first to identify new problems and propose novel, if not easy, solutions; detailed examination of his career; photos (L)", "print_page": "1", "word_count": 3323, "_id": "4fd2266f8eb7c8105d7ae166", "snippet": "Daniel Patrick Moynihan, the Harvard professor and four-term United States senator from New York who brought a scholar's eye for data to politics and a politician's sense of the real world to academia, died yesterday at Washington Hospital Center in...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/03/27/nyregion/daniel-patrick-moynihan-is-dead-senator-from-academia-was-76.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "MOYNIHAN, DANIEL PATRICK"}, {"name": "glocations", "value": "NEW YORK STATE"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "CONGRESS"}, {"name": "organizations", "value": "SENATE"}, {"name": "subject", "value": "UNITED STATES POLITICS AND GOVERNMENT"}, {"name": "subject", "value": "BIOGRAPHICAL INFORMATION"}, {"name": "subject", "value": "ELECTIONS"}, {"name": "subject", "value": "DEATHS (OBITUARIES)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Adam", "lastname": "CLYMER"}], "original": "By ADAM CLYMER"}, "document_type": "article", "pub_date": "2003-03-27T00:00:00Z", "section_name": "Front Page; Washington; Obituaries; New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Money and Business/Financial Desk", "lead_paragraph": "AFTER anthrax spread through the mail in October 2001, the government began a crash program to develop drugs, vaccines and diagnostic tests to protect the nation from biological terrorism. The pharmaceutical industry pledged support. It seemed to be the dawn of a new defense industry, based on genes instead of jets. But with the nation now at war in Iraq, which is presumed to have biological weapons, the efforts to create a vibrant biodefense sector have had only partial success.", "headline": {"main": "Untested Companies Enlist in U.S. Biodefense"}, "abstract": "Efforts in United States to create vibrant biodefense sector have left national security against bioterorism largely in hands of untested companies; about 100 biotechnology companies are trying to develop technology for detecting or fighting pathogens that may be used by terrorists or rogue nations; many are small companies, lured by government research money, that have never brought product to market successfully; Bush administration plan to spend some $6 billion over 10 years to buy and stockpile medicines to counter biological, chemical and radiological weapons will create guaranteed market for drugs; table of possible threats and companies working to counter them; photos (M)", "print_page": "1", "word_count": 2214, "_id": "4fd226728eb7c8105d7ae35c", "snippet": "AFTER anthrax spread through the mail in October 2001, the government began a crash program to develop drugs, vaccines and diagnostic tests to protect the nation from biological terrorism. The pharmaceutical industry pledged support. It seemed to be...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/03/23/business/untested-companies-enlist-in-us-biodefense.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "ATOMIC WEAPONS"}, {"name": "subject", "value": "BIOLOGICAL AND CHEMICAL WARFARE"}, {"name": "subject", "value": "RADIATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}, {"name": "subject", "value": "TERRORISM"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Melody", "lastname": "PETERSEN"}], "original": "By ANDREW POLLACK with MELODY PETERSEN"}, "document_type": "article", "pub_date": "2003-03-23T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 2, "offset": 0, "time": 39}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}